Chances are many of your older female patients have either stopped using hormone replacement therapy or are still mulling over the pros and cons since the Women's Health Initiative found conflicting data about its health benefits and risks.
Day 2 Recap: Maui Derm NP+PA Fall 2024
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
LEO Pharma's Tralokinumab-ldrm Autoinjector Now Available in US for Adults With Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Importance of APPs in Treating and Understanding AD
Infectious Disease and Dermatology Crossover: What Providers Need to Know